{"product_id":"exercise-and-the-heart-the-good-the-bad-and-the-ugly-what-patients-need-to-know","title":"Exercise and the Heart: The Good, The Bad, and The Ugly — What Patients Need to Know","description":"\u003cp\u003eRegular exercise is one of the most powerful \"medicines\" a doctor can prescribe—it cuts the risk of heart attack by 50%, extends lifespan by at least 3 years, and protects against dementia, depression, and some cancers. However, this comprehensive clinical review from the \u003cem\u003eEuropean Heart Journal\u003c\/em\u003e explains that while moderate exercise is undeniably beneficial, extreme endurance training can cause concerning heart changes in a small number of athletes, and performance-enhancing drugs pose serious cardiovascular dangers. This patient-friendly guide walks you through the \"good, bad, and ugly\" of exercise and heart health, translating all the study data so you can understand exactly what the research shows.\u003c\/p\u003e\n\n\u003ch1\u003eExercise and the Heart: The Good, The Bad, and The Ugly — What Patients Need to Know\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#introduction\"\u003eIntroduction: Why This Research Matters\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#the-good\"\u003eThe Good: How Exercise Protects Your Heart\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#athletes-heart\"\u003eThe Athlete's Heart: What Happens to the Heart with Intense Training\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#athletes-ecg\"\u003eThe Athlete's ECG: Electrical Changes from Training\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#cardiac-dimensions\"\u003eCardiac Dimensions: How Much Can a Heart Grow?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#upper-limits\"\u003eUpper Limits of Normal Cardiac Size in Athletes\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#differentiating\"\u003eDistinguishing Athlete's Heart from Heart Muscle Disease\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#sudden-death\"\u003eThe Bad: Sudden Cardiac Death in Sport\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#exercise-damage\"\u003eCan Exercise Damage a Previously Normal Heart?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#atrial-fibrillation\"\u003eAtrial Fibrillation and Sinus Node Disease in Athletes\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ventricular-arrhythmias\"\u003eAdverse Cardiac Remodelling and Ventricular Arrhythmias\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#performance-drugs\"\u003eThe Ugly: Performance-Enhancing Drugs and the Heart\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eLimitations of the Current Research\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations: What Does This Mean for You?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eModerate exercise of about 2 hours weekly lowers cardiovascular mortality; each MET of exercise gives a 12–20% reduction.\u003c\/li\u003e\n\u003cli\u003eAthlete's heart includes 10–20% thicker left ventricular wall and 10–15% larger cavities; usually benign and reversible with detraining.\u003c\/li\u003e\n\u003cli\u003eIn 102 veteran marathon runners, 12% showed myocardial fibrosis on MRI compared with 4% of controls, suggesting extreme endurance exercise may harm some.\u003c\/li\u003e\n\u003cli\u003eEndurance athletes have a 5-fold higher atrial fibrillation risk per a meta-analysis of 655 athletes; more training hours raise the risk.\u003c\/li\u003e\n\u003cli\u003eAnabolic steroids and cocaine can cause heart attacks, heart failure, arrhythmias, and sudden death; no safe dose exists.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"introduction\"\u003eIntroduction: Why This Research Matters\u003c\/h2\u003e\n\u003cp\u003eExercise is universally recommended for heart health, but this review by Dr. Sanjay Sharma and colleagues from St George's University of London and the University of Barcelona tackles a more complex question: is there a point where exercise stops being helpful and starts becoming harmful?\u003c\/p\u003e\n\u003cp\u003eThe authors divide sports cardiology into three categories. The \u003cstrong\u003e\"good\"\u003c\/strong\u003e covers the well-proven benefits of moderate exercise. The \u003cstrong\u003e\"bad\"\u003c\/strong\u003e refers to the rare but tragic occurrence of sudden cardiac death in athletes with undiagnosed heart conditions. The \u003cstrong\u003e\"ugly\"\u003c\/strong\u003e describes two concerning trends: emerging evidence that decades of extreme endurance exercise may damage otherwise normal hearts, and the dangerous use of performance-enhancing drugs in competitive sports.\u003c\/p\u003e\n\n\u003ch2 id=\"the-good\"\u003eThe Good: How Exercise Protects Your Heart\u003c\/h2\u003e\n\u003cp\u003eThe cardiovascular benefits of regular exercise have been recognized for decades. Exercise helps control blood pressure, improves the blood lipid (fat) profile by raising \"good\" HDL cholesterol and lowering \"bad\" LDL cholesterol, and increases insulin sensitivity, which helps prevent type 2 diabetes.\u003c\/p\u003e\n\u003cp\u003eIn the 1950s, researcher Morris and colleagues made a landmark observation: active bus workers and postal workers had a \u003cstrong\u003e50% lower rate of coronary artery disease (CAD)\u003c\/strong\u003e events compared with their less active colleagues—sedentary bus drivers and clerical postal workers. A more recent study of over \u003cstrong\u003e44,000 professional men\u003c\/strong\u003e followed for \u003cstrong\u003e475,755 person-years\u003c\/strong\u003e confirmed that regular exercise reduces coronary event rates by a similar magnitude.\u003c\/p\u003e\n\u003cp\u003eHow much exercise is needed to achieve these benefits? Surprisingly little. The research shows that just \u003cstrong\u003e2 hours of exercise per week\u003c\/strong\u003e at an intensity of \u003cstrong\u003e6–10 metabolic equivalents of task (METS)\u003c\/strong\u003e—think of a brisk walk, a gentle jog at 6.4–8 km\/h, or cycling at 15–20 km\/h—divided over three exercise sessions is enough. Even lower-intensity exercise provides meaningful protection compared with being completely sedentary. For every single MET of exercise achieved, there is a \u003cstrong\u003e12–20% reduction in cardiovascular mortality\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eFor patients who already have heart disease, exercise is still powerful medicine. A systematic review and meta-analysis of \u003cstrong\u003e34 randomized controlled trials\u003c\/strong\u003e looking at exercise-based cardiac rehabilitation after a heart attack found a lower risk of a second heart attack, lower cardiac mortality, and lower all-cause mortality in patients who participated in structured exercise programs. In patients with heart failure, regular physical activity improves functional capacity and modestly reduces hospitalizations and death from all causes.\u003c\/p\u003e\n\u003cp\u003eThe benefits go beyond the heart. Regular exercise reduces the risk of prostate and breast cancer, prevents osteoporosis (bone thinning), and may delay the onset of dementia. Exercise also improves stamina, boosts self-confidence, and is widely considered an antidepressant. In terms of longevity, people who exercise regularly live \u003cstrong\u003eat least 3 years longer\u003c\/strong\u003e than their sedentary counterparts. The authors emphasize that exercise may be the most effective, accessible, and cheapest therapy a physician can prescribe—especially in an era of rising obesity rates approaching epidemic levels in some Western regions.\u003c\/p\u003e\n\n\u003ch2 id=\"athletes-heart\"\u003eThe Athlete's Heart: What Happens to the Heart with Intense Training\u003c\/h2\u003e\n\u003cp\u003eCurrent European and American guidelines recommend a minimum of \u003cstrong\u003e150 minutes of moderate-intensity exercise per week\u003c\/strong\u003e for adults. But competitive athletes—and some dedicated recreational athletes—perform far beyond these recommendations, regularly engaging in over \u003cstrong\u003e20 hours of intense exercise (15 METS) per week\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThis level of training demands a sustained \u003cstrong\u003e5-to-6-fold increase in cardiac output\u003c\/strong\u003e (the amount of blood the heart pumps per minute), sustained for long periods. To meet this demand, the heart undergoes a series of unique electrical, structural, and functional adaptations collectively known as the \u003cstrong\u003e\"athlete's heart\"\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn general, athletes develop a \u003cstrong\u003e10–20% increase in left ventricular (LV) wall thickness\u003c\/strong\u003e and a \u003cstrong\u003e10–15% increase in both left and right ventricular cavity size\u003c\/strong\u003e compared with non-athletes of similar age and size. Athletes also show enhanced cardiac filling during diastole (the relaxation phase of the heartbeat), maintain high stroke volume even at very rapid heart rates, and develop increased oxidative capacity and capillary density in skeletal muscle—all of which contribute to the high peak oxygen consumption seen in elite athletes.\u003c\/p\u003e\n\n\u003ch2 id=\"athletes-ecg\"\u003eThe Athlete's ECG: Electrical Changes from Training\u003c\/h2\u003e\n\u003cp\u003eThe electrocardiogram (ECG) of a trained athlete often looks quite different from a normal resting ECG. These changes fall into two broad categories: those caused by high vagal tone (the part of the nervous system that slows the heart) and those reflecting increased heart chamber size.\u003c\/p\u003e\n\u003cp\u003eCommon ECG patterns in athletes include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eSinus bradycardia (a slow resting heart rate)\u003c\/li\u003e\n  \u003cli\u003eSinus arrhythmia (irregular but normal heart rhythm)\u003c\/li\u003e\n  \u003cli\u003eJ-point elevation with ascending ST segments (a benign pattern)\u003c\/li\u003e\n  \u003cli\u003eFirst-degree atrioventricular (AV) block (slight delay in electrical conduction)\u003c\/li\u003e\n  \u003cli\u003eVoltage criteria for left and right ventricular hypertrophy (enlargement)\u003c\/li\u003e\n  \u003cli\u003eIncomplete right bundle branch block (a partial delay in the heart's electrical system)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSome athletes even show a nodal rhythm or Mobitz type 1 second-degree AV block at rest, which resolves with mild exertion—both are considered normal in this population.\u003c\/p\u003e\n\u003cp\u003eImportantly, \u003cstrong\u003eethnicity changes what is \"normal\" on an athlete's ECG\u003c\/strong\u003e. Athletes of African and Afro-Caribbean origin (black athletes) show more pronounced repolarization changes compared with white athletes. ST segment elevation is \u003cstrong\u003e6-fold greater\u003c\/strong\u003e in black athletes than white athletes. T-wave inversion—which would be considered abnormal in most adult white athletes—is present in up to \u003cstrong\u003e25% of black athletes\u003c\/strong\u003e. The most common pattern in black athletes is asymmetric deep T-wave inversion preceded by convex ST-segment elevation in leads V1–V4, which has not been shown to correlate with heart disease or poor outcomes. T-wave inversion in the inferior leads is probably also a normal variant in black athletes.\u003c\/p\u003e\n\u003cp\u003eAxis deviation and voltage criteria for atrial enlargement are considered normal variants when they appear in isolation and do not require further investigation if the athlete has no symptoms, a normal physical examination, and no relevant family history.\u003c\/p\u003e\n\n\u003ch2 id=\"cardiac-dimensions\"\u003eCardiac Dimensions: How Much Can a Heart Grow?\u003c\/h2\u003e\n\u003cp\u003eThe increased preload and afterload associated with chronic intensive exercise leads to symmetrical enlargement of all four heart chambers. Up to \u003cstrong\u003e50% of male athletes\u003c\/strong\u003e show left and right ventricular cavity dimensions that exceed the predicted upper limits for the general population.\u003c\/p\u003e\n\u003cp\u003eA study of over \u003cstrong\u003e1,300 white Italian Olympic athletes\u003c\/strong\u003e found that 45% had left ventricular cavity sizes exceeding predicted upper limits, and \u003cstrong\u003e14% had a cavity size greater than 60 mm\u003c\/strong\u003e—a dimension that could otherwise be consistent with dilated cardiomyopathy, a serious heart muscle disease.\u003c\/p\u003e\n\u003cp\u003eA more recent study of almost \u003cstrong\u003e700 nationally ranked black and white athletes\u003c\/strong\u003e revealed that almost \u003cstrong\u003e40% of male athletes exhibited right ventricular enlargement\u003c\/strong\u003e similar to that observed in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), a genetic condition that predisposes to dangerous heart rhythms.\u003c\/p\u003e\n\u003cp\u003eWhile athletes show a slightly increased aortic root diameter compared with sedentary individuals, an aortic root larger than 40 mm is rare and should be considered abnormal.\u003c\/p\u003e\n\n\u003ch2 id=\"upper-limits\"\u003eUpper Limits of Normal Cardiac Size in Athletes\u003c\/h2\u003e\n\u003cp\u003eThe upper limits for cardiac dimensions in athletes vary by ethnicity, age, and sex. The table below summarizes the key values from the research:\u003c\/p\u003e\n\u003ctable border=\"1\" cellpadding=\"5\" cellspacing=\"0\"\u003e\n  \u003ctr\u003e\n    \u003cth\u003eAthlete Group\u003c\/th\u003e\n    \u003cth\u003eLVEDD (mm)\u003c\/th\u003e\n    \u003cth\u003eLVWT (mm)\u003c\/th\u003e\n    \u003cth\u003eRVD1 (mm)\u003c\/th\u003e\n    \u003cth\u003eRVOT1 (mm)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eNon-athletes\u003c\/strong\u003e – Male\u003c\/td\u003e\n    \u003ctd\u003e59\u003c\/td\u003e\n    \u003ctd\u003e10\u003c\/td\u003e\n    \u003ctd\u003e38\u003c\/td\u003e\n    \u003ctd\u003e35\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eNon-athletes\u003c\/strong\u003e – Female\u003c\/td\u003e\n    \u003ctd\u003e53\u003c\/td\u003e\n    \u003ctd\u003e9\u003c\/td\u003e\n    \u003ctd\u003e38\u003c\/td\u003e\n    \u003ctd\u003e35\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eCaucasian adult athletes\u003c\/strong\u003e – Male\u003c\/td\u003e\n    \u003ctd\u003e63\u003c\/td\u003e\n    \u003ctd\u003e12\u003c\/td\u003e\n    \u003ctd\u003e55\u003c\/td\u003e\n    \u003ctd\u003e43\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eCaucasian adult athletes\u003c\/strong\u003e – Female\u003c\/td\u003e\n    \u003ctd\u003e56\u003c\/td\u003e\n    \u003ctd\u003e11\u003c\/td\u003e\n    \u003ctd\u003e49\u003c\/td\u003e\n    \u003ctd\u003e40\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eCaucasian adolescent athletes (14–18)\u003c\/strong\u003e – Male\u003c\/td\u003e\n    \u003ctd\u003e58\u003c\/td\u003e\n    \u003ctd\u003e12\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eCaucasian adolescent athletes (14–18)\u003c\/strong\u003e – Female\u003c\/td\u003e\n    \u003ctd\u003e54\u003c\/td\u003e\n    \u003ctd\u003e11\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eBlack adult athletes\u003c\/strong\u003e – Male\u003c\/td\u003e\n    \u003ctd\u003e62\u003c\/td\u003e\n    \u003ctd\u003e15\u003c\/td\u003e\n    \u003ctd\u003e55\u003c\/td\u003e\n    \u003ctd\u003e43\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eBlack adult athletes\u003c\/strong\u003e – Female\u003c\/td\u003e\n    \u003ctd\u003e56\u003c\/td\u003e\n    \u003ctd\u003e12\u003c\/td\u003e\n    \u003ctd\u003e49\u003c\/td\u003e\n    \u003ctd\u003e40\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eBlack adolescent athletes (14–18)\u003c\/strong\u003e – Male\u003c\/td\u003e\n    \u003ctd\u003e62\u003c\/td\u003e\n    \u003ctd\u003e15\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e\n\u003cstrong\u003eBlack adolescent athletes (14–18)\u003c\/strong\u003e – Female\u003c\/td\u003e\n    \u003ctd\u003e56\u003c\/td\u003e\n    \u003ctd\u003e11\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cem\u003eLVEDD = left ventricular end-diastolic diameter; LVWT = left ventricular wall thickness; RVD1 = basal right ventricular internal diameter; RVOT1 = right ventricular outflow tract.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003eIn absolute terms, LV wall thickness in athletes is usually within the normal range for the general population (8–12 mm). Only \u003cstrong\u003e2% of Caucasian athletes\u003c\/strong\u003e show an LV wall thickness greater than 12 mm, and such dimensions are confined to male athletes. In contrast, LV hypertrophy above 12 mm is relatively common in black male athletes—up to \u003cstrong\u003e13% of black males and 3% of black females\u003c\/strong\u003e show an LV wall thickness of 12 mm or more. Regardless of ethnicity, an LV wall thickness \u003cstrong\u003egreater than 16 mm is extremely uncommon\u003c\/strong\u003e and should raise concern for hypertrophic cardiomyopathy. These cardiac adaptations are smaller in adolescent athletes, who are generally less physically mature and have trained for shorter periods. The largest cardiac dimensions are typically found in male endurance athletes with large body surface areas, particularly rowers and long-distance cyclists.\u003c\/p\u003e\n\n\u003ch2 id=\"differentiating\"\u003eDistinguishing Athlete's Heart from Heart Muscle Disease (Cardiomyopathy)\u003c\/h2\u003e\n\u003cp\u003eHere is the diagnostic challenge at the heart of sports cardiology: the same cardiac changes that occur naturally in response to training can also be signs of a cardiomyopathy—a disease of the heart muscle that can be life-threatening.\u003c\/p\u003e\n\u003cp\u003eThe electrical and structural changes in an athlete's heart are considered benign and generally reversible after a period of detraining. However, when LV hypertrophy combines with abnormal repolarization changes, or when an enlarged ventricular cavity coexists with a borderline low ejection fraction (the heart's pumping efficiency), the picture can overlap with a cardiomyopathy. This is especially relevant in black athletes, who have a higher prevalence of both LV hypertrophy and repolarization changes, and in endurance athletes, who may have very large ventricular cavities with borderline low ejection fractions.\u003c\/p\u003e\n\u003cp\u003eTo make the distinction, doctors use a combination of tests including ECG, echocardiography (ultrasound of the heart), cardiopulmonary exercise testing with exercise echocardiography, cardiac magnetic resonance imaging (CMRI), 24-hour Holter ECG monitoring, and genetic testing. An expert evaluation is essential because an erroneous diagnosis of cardiomyopathy may result in unnecessary disqualification from sport, while an erroneous diagnosis of \"athlete's heart\" in someone who actually has a cardiomyopathy may put a young life at risk.\u003c\/p\u003e\n\u003cp\u003eSigns that strongly suggest a cardiomyopathy rather than athlete's heart include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eST segment depression in any lead\u003c\/li\u003e\n  \u003cli\u003eT-wave inversion in the lateral leads\u003c\/li\u003e\n  \u003cli\u003ePathological q waves (Q\/R ratio greater than 0.25)\u003c\/li\u003e\n  \u003cli\u003eLeft bundle branch block on the ECG\u003c\/li\u003e\n  \u003cli\u003eAbnormal indices of diastolic function\u003c\/li\u003e\n  \u003cli\u003eReduced longitudinal systolic function\u003c\/li\u003e\n  \u003cli\u003eRegional wall motion abnormalities\u003c\/li\u003e\n  \u003cli\u003eEvidence of late gadolinium enhancement (scar tissue) on cardiac MRI\u003c\/li\u003e\n  \u003cli\u003eExercise-induced arrhythmias\u003c\/li\u003e\n  \u003cli\u003eComplex ventricular arrhythmias on a Holter monitor\u003c\/li\u003e\n  \u003cli\u003eLow peak oxygen consumption (below 50 mL\/min\/kg or below 120% of predicted)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn athletes with LV hypertrophy measuring 13–16 mm, the additional finding of a relatively small LV cavity (less than 50 mm) and dynamic LV outflow obstruction during exercise would point toward \u003cstrong\u003ehypertrophic cardiomyopathy\u003c\/strong\u003e. In athletes with a dilated LV and borderline low ejection fraction, a failure to improve LV function or a peak oxygen consumption below 50 mL\/min\/kg (or below 120% of predicted) would favor \u003cstrong\u003edilated cardiomyopathy\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn an athlete with a dilated right ventricle, the following findings suggest \u003cstrong\u003earrhythmogenic right ventricular cardiomyopathy (ARVC)\u003c\/strong\u003e: regional wall motion abnormalities or akinetic (non-moving) segments, T-wave inversion in leads V1–V3 with isoelectric ST segments or ST segment depression, epsilon waves (small deflections at the end of the QRS complex), low-amplitude QRS complexes in the limb leads, late potentials on signal-averaged ECG, and more than 1,000 extra-systoles (premature heartbeats) on monitoring.\u003c\/p\u003e\n\u003cp\u003eThe review also discusses \u003cstrong\u003eleft ventricular non-compaction (LVNC)\u003c\/strong\u003e, a relatively newly recognized myocardial disorder characterized by increased LV trabeculation (a spongy appearance of the heart muscle), impaired systolic function, and a tendency toward fatal arrhythmias. The diagnosis is based on imaging showing a double-layered myocardial structure where the non-compacted-to-compacted layer thickness ratio is at least 2:1. The authors' experience reveals that almost \u003cstrong\u003e20% of young athletes\u003c\/strong\u003e show increased LV trabeculation, and \u003cstrong\u003e8% fulfill diagnostic criteria for LVNC\u003c\/strong\u003e on imaging. They propose that a pathological diagnosis of LVNC in athletes should only be made if there is reduced LV function, lateral T-wave inversion on ECG, low peak oxygen consumption, ventricular arrhythmias on exercise testing or Holter monitoring, or evidence of fibrosis on cardiac MRI.\u003c\/p\u003e\n\u003cp\u003eWhen all investigations fail to resolve the diagnostic dilemma, a period of \u003cstrong\u003edetraining for 6–8 weeks\u003c\/strong\u003e is advised to check whether the electrical and structural changes regress. Although this approach seems sensible, the authors note that convincing competitive athletes to detrain is difficult because it compromises fitness and team selection.\u003c\/p\u003e\n\n\u003ch2 id=\"sudden-death\"\u003eThe Bad: Sudden Cardiac Death in Sport\u003c\/h2\u003e\n\u003cp\u003eOccasionally, an athlete dies suddenly during or immediately after competition. These tragedies are rare, but they strike young athletes harboring undiagnosed cardiomyopathies, coronary artery disease, accessory pathways (extra electrical connections in the heart), or ion channel disorders (conditions affecting the heart's electrical signaling). Middle-aged athletes who die suddenly typically have advanced coronary atherosclerosis (hardening and narrowing of the coronary arteries).\u003c\/p\u003e\n\u003cp\u003eThe prevalence of sudden cardiac death (SCD) varies depending on how data are collected, but the most reliable data reveal a prevalence of approximately \u003cstrong\u003e1 in 50,000\u003c\/strong\u003e in young competitive athletes and in middle-aged marathon runners. \u003cstrong\u003eNinety percent of victims are male.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAlthough deaths in competitive athletes receive considerable media attention, over \u003cstrong\u003e90% of all exercise-related sudden cardiac deaths occur in recreational athletes\u003c\/strong\u003e—a crucial point that is often lost in the headlines.\u003c\/p\u003e\n\u003cp\u003eCardiovascular screening to identify athletes at risk of exercise-related SCD remains controversial because event rates are so low. However, data from a large prospective Italian study indicate that evaluating young athletes with a 12-lead ECG is effective in reducing the risk of SCD. The success of the Italian program is attributed to the ECG's ability to detect ion channel disease and accessory pathways, and because most patients with a primary cardiomyopathy exhibit an abnormal ECG. In contrast, most middle-aged athletes who die from coronary artery disease rarely show abnormalities on a resting ECG. Current recommendations for identifying middle-aged athletes at highest risk of SCD rely on an exercise stress test—but it is recognized that most abnormal exercise tests in asymptomatic middle-aged athletes are false positives and have low predictive accuracy.\u003c\/p\u003e\n\u003cp\u003eCurrent data suggest that \u003cstrong\u003ebystander cardiopulmonary resuscitation (CPR) and early use of an automated external defibrillator (AED)\u003c\/strong\u003e are the most effective methods of preventing SCD in this group. In most instances of SCD in sport, the reputation of exercise remains intact because exercise is considered a mere trigger for arrhythmias in predisposed individuals, rather than the cause of the underlying pathological condition.\u003c\/p\u003e\n\n\u003ch2 id=\"exercise-damage\"\u003eCan Exercise Damage a Previously Normal Heart?\u003c\/h2\u003e\n\u003cp\u003eThe past two decades have witnessed a surge in the number of people participating in grueling endurance events such as competitive cycling, marathons, triathlons, and Ironman races. In parallel, multiple studies have demonstrated raised blood concentrations of cardiac damage biomarkers (such as cardiac troponin) in a large number of these athletes after events.\u003c\/p\u003e\n\u003cp\u003eThe mechanism and consequences of elevated cardiac biomarkers after exercise are debated. The key question the authors raise: could repeated bouts of lifelong endurance exercise, in some individuals with an otherwise normal heart, cause enough heart muscle cell death (myocyte necrosis) to create an arrhythmogenic substrate through adverse myocardial remodelling and fibrosis (scarring)?\u003c\/p\u003e\n\u003cp\u003eEvidence from animal models supports this theory. \u003cstrong\u003eBenito and colleagues\u003c\/strong\u003e exercised rats on a treadmill for 16 weeks—which in human terms is equivalent to approximately 10 years. At the end of the study, the exercising rats had developed eccentric LV hypertrophy, diastolic dysfunction, and diffuse fibrosis in the atria and right ventricle. More importantly, ventricular tachycardia (a dangerous rapid heart rhythm) was inducible during electrophysiological studies in \u003cstrong\u003e42% of the exercising rats compared with only 6% of sedentary rats\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eHuman cross-sectional studies have also explored the role of chronic endurance exercise in myocardial fibrosis. \u003cstrong\u003eBreuckmann and colleagues\u003c\/strong\u003e performed cardiac MRI on \u003cstrong\u003e102 men aged 50 years and older\u003c\/strong\u003e who had completed at least five marathons during the previous 3 years and had no history of heart disease or diabetes. Veteran marathon runners exhibited a \u003cstrong\u003e3-fold greater prevalence of late gadolinium enhancement (LGE)\u003c\/strong\u003e—an indicator of myocardial fibrosis or scar—compared with sedentary controls (12% vs. 4%).\u003c\/p\u003e\n\u003cp\u003eAnother study by \u003cstrong\u003eMohlenkamp and colleagues\u003c\/strong\u003e assessed coronary artery calcium scores in the same cohort and found that a larger proportion of marathon runners had coronary artery calcium scores above 100 Agatston Units (a measure of plaque buildup) compared with controls matched for age and Framingham risk factors (36% vs. 21%). The researchers implicated shearing forces within coronary arteries during high heart rates, circulating interleukins due to inflammation, and the production of free radicals as possible contributing factors.\u003c\/p\u003e\n\n\u003ch2 id=\"atrial-fibrillation\"\u003eAtrial Fibrillation and Sinus Node Disease in Athletes\u003c\/h2\u003e\n\u003cp\u003ePerhaps the most persuasive data suggesting that excessive endurance exercise could prove detrimental for some athletes comes from the higher-than-expected prevalence of \u003cstrong\u003eatrial fibrillation (AF)\u003c\/strong\u003e—a common irregular heart rhythm—in middle-aged endurance athletes.\u003c\/p\u003e\n\u003cp\u003eA meta-analysis of \u003cstrong\u003e6 studies involving 655 athletes\u003c\/strong\u003e engaged in chronic exercise reported a \u003cstrong\u003e5-fold higher risk of AF\u003c\/strong\u003e compared with the sedentary population. In a recent large study of \u003cstrong\u003e52,000 long-distance cross-country skiers\u003c\/strong\u003e, the risk of AF was related to the number of races competed in and faster finishing times.\u003c\/p\u003e\n\u003cp\u003eSome studies have assigned specific exercise risk thresholds for developing AF:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eA lifetime sports practice exceeding \u003cstrong\u003e1,500 hours\u003c\/strong\u003e increases the risk\u003c\/li\u003e\n  \u003cli\u003eMore than \u003cstrong\u003e5 hours of intensive exercise per week\u003c\/strong\u003e starting at age 30 years and onward increases the risk of AF\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe precise mechanism behind AF in athletes is not fully understood, but researchers have implicated vagally mediated shortening of the atrial refractory period (the time heart tissue needs to recover before it can beat again), atrial stretch, atrial inflammation, and scarring. Animal models support the theory that AF in athletes is a consequence of adverse atrial remodelling. One recent study demonstrated that rats subjected to intensive exercise for 1 hour per day for a total of 16 weeks displayed atrial dilatation, scarring, and an enhanced sensitivity to AF induction.\u003c\/p\u003e\n\u003cp\u003eAthletes also show a higher prevalence of \u003cstrong\u003esinus node dysfunction\u003c\/strong\u003e (problems with the heart's natural pacemaker) and second- or third-degree AV block compared with non-athletes, though these are often benign in young athletes.\u003c\/p\u003e\n\n\u003ch2 id=\"ventricular-arrhythmias\"\u003eAdverse Cardiac Remodelling and Ventricular Arrhythmias\u003c\/h2\u003e\n\u003cp\u003eThere is emerging evidence that ventricular arrhythmias (dangerous rhythms originating in the lower chambers of the heart) in an otherwise healthy athlete may have a more sinister prognosis than previously thought.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHeidbuchel and colleagues\u003c\/strong\u003e observed a high incidence of major arrhythmic events including sudden cardiac death (\u003cstrong\u003e20%\u003c\/strong\u003e) in \u003cstrong\u003e46 young athletes\u003c\/strong\u003e presenting with frequent ventricular ectopy (extra heartbeats) or non-sustained ventricular tachycardia over a \u003cstrong\u003e5-year follow-up period\u003c\/strong\u003e. Notably, \u003cstrong\u003e80% of the ventricular arrhythmias were of right ventricular origin\u003c\/strong\u003e—pointing to the right side of the heart as a vulnerable area.\u003c\/p\u003e\n\u003cp\u003eSubsequent studies from the same group suggest that chronic endurance exercise promotes adverse right ventricular remodelling. During exercise, invasive studies reveal that pulmonary artery pressures can reach as high as \u003cstrong\u003e80 mmHg\u003c\/strong\u003e, placing a heavy load (afterload) on the right ventricle. \u003cstrong\u003eLa Gerche and colleagues\u003c\/strong\u003e studied \u003cstrong\u003e40 healthy athletes\u003c\/strong\u003e at baseline and after an endurance race, revealing transient right ventricular enlargement associated with impaired right ventricular function on echocardiography. Cardiac troponin and B-type natriuretic peptide levels (blood markers of heart strain) were elevated and corresponded to the duration of exercise and the magnitude of reduction in right ventricular function.\u003c\/p\u003e\n\u003cp\u003eThe researchers postulated that repeated insults to the right ventricle of this type, following prolonged intense exercise, could lead to the concept of \u003cstrong\u003eexercise-induced ARVC\u003c\/strong\u003e—a condition in which years of endurance training cause changes that mimic a genetic heart muscle disease. The dose of exercise required for this effect is probably \u003cstrong\u003emore than 20 hours per week for more than 20 years\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch2 id=\"performance-drugs\"\u003eThe Ugly: Performance-Enhancing Drugs and the Heart\u003c\/h2\u003e\n\u003cp\u003eIn the current era of celebrity athletes and lucrative sports contracts, several athletes have turned to performance-enhancing agents for success—with devastating consequences for cardiac health. The table below summarizes the effects of various performance-enhancing drugs on the heart:\u003c\/p\u003e\n\u003ctable border=\"1\" cellpadding=\"5\" cellspacing=\"0\"\u003e\n  \u003ctr\u003e\n    \u003cth\u003eSubstance\u003c\/th\u003e\n    \u003cth\u003eHigh Blood Pressure\u003c\/th\u003e\n    \u003cth\u003eArrhythmias\u003c\/th\u003e\n    \u003cth\u003eLV Hypertrophy\u003c\/th\u003e\n    \u003cth\u003eCoronary Artery Disease\u003c\/th\u003e\n    \u003cth\u003eHeart Attack\u003c\/th\u003e\n    \u003cth\u003eHeart Failure\u003c\/th\u003e\n    \u003cth\u003eSudden Cardiac Death\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eAnabolic androgens\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eHuman chorionic gonadotrophin\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eErythropoietin\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eB2 agonists\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDiuretics\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eAmphetamines\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCocaine\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eEphedrine\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eNarcotics\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCannabinoids\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eGlucocorticoids\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eAlcohol\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n    \u003ctd\u003e—\u003c\/td\u003e\n    \u003ctd\u003e✓\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cem\u003eLV = left ventricle; ✓ indicates a documented harmful effect on the heart.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAnabolic androgens\u003c\/strong\u003e (anabolic steroids) are particularly dangerous, as they can cause high blood pressure, arrhythmias, left ventricular hypertrophy (thickening of the heart muscle), coronary artery disease, heart attacks, heart failure, and sudden cardiac death. \u003cstrong\u003eCocaine\u003c\/strong\u003e is equally harmful across all categories. \u003cstrong\u003eAmphetamines\u003c\/strong\u003e, \u003cstrong\u003eephedrine\u003c\/strong\u003e, and \u003cstrong\u003ealcohol\u003c\/strong\u003e also carry significant cardiac risks, including heart attacks and sudden death.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eLimitations of the Current Research\u003c\/h2\u003e\n\u003cp\u003eThe authors are careful to point out the limitations of the evidence suggesting that extreme exercise can damage the heart. While there are mounting reports that regular participation in extremely intensive exercise may induce arrhythmogenic cardiac substrates in some athletes, these conclusions remain speculative. Much of the evidence is based on observational studies involving small, selected groups of symptomatic athletes who presented to medical professionals.\u003c\/p\u003e\n\u003cp\u003eIf such cases represented the \"numerator\" of athletes harboring exercise-induced arrhythmogenic substrates, the percentage of athletes affected would be minuscule when considering the likely \"denominator\" of approximately \u003cstrong\u003e10 million participants\u003c\/strong\u003e in marathons, triathlons, and Ironman events worldwide each year.\u003c\/p\u003e\n\u003cp\u003eImportantly, a prospective study of \u003cstrong\u003e114 Olympic endurance athletes\u003c\/strong\u003e who had competed in 2–5 consecutive Olympic Games did not show any deterioration in cardiac function or increased risk of arrhythmias over time. Exercise also reduces age-related decreases in arterial compliance and elasticity, which may protect against cardiovascular disease in later life.\u003c\/p\u003e\n\u003cp\u003eFurthermore, numerous studies have revealed that athletes engaging in the most grueling endurance events—including the Tour de France—live longer than inactive individuals. This longevity benefit may be attributed to their generally healthier lifestyle or genetic superiority, but it should not obscure the fact that years of intensive exercise were not associated with an increased risk of cardiac morbidity in these athletes.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations: What Does This Mean for You?\u003c\/h2\u003e\n\u003cp\u003eBased on this comprehensive review, here is what patients should take away:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eModerate exercise is powerfully protective.\u003c\/strong\u003e Aim for at least 150 minutes of moderate-intensity exercise per week (about 2 hours total), which can be divided into three sessions of 40–50 minutes each. Brisk walking, gentle jogging, or cycling all count.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEven small amounts help.\u003c\/strong\u003e Every single MET of exercise you achieve reduces cardiovascular mortality by 12–20%, and even light activity is better than being completely sedentary.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eExercise is medicine for existing heart disease too.\u003c\/strong\u003e Structured cardiac rehabilitation after a heart attack reduces the risk of future cardiac events and death, based on evidence from 34 randomized trials.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you are an endurance athlete, know your body.\u003c\/strong\u003e While extreme endurance training appears safe for the vast majority, the data suggest a small subset of athletes may develop heart rhythm problems or structural changes with decades of very high-volume training (more than 20 hours per week for more than 20 years).\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePay attention to symptoms.\u003c\/strong\u003e Symptoms such as chest pain, fainting, palpitations, or unusual shortness of breath during exercise should never be ignored, especially in athletes with a family history of heart disease or sudden death.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIf you are over 30 and exercising intensively, be aware of atrial fibrillation risk.\u003c\/strong\u003e More than 5 hours of intensive exercise weekly starting at age 30, or more than 1,500 cumulative lifetime hours of sports, has been associated with a higher risk of AF.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNever use performance-enhancing drugs.\u003c\/strong\u003e Substances like anabolic steroids and cocaine can cause catastrophic cardiac damage—including heart attacks, heart failure, and sudden death—with no safe threshold.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBlack athletes should be evaluated with ethnicity-specific standards.\u003c\/strong\u003e ECG patterns and cardiac dimensions that would be concerning in white athletes may be completely normal in black athletes.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eHow much exercise do I need to protect my heart?\u003c\/h3\u003e\n\u003cp\u003eJust 2 hours of moderate exercise per week, divided into three sessions, is enough. That means brisk walking, gentle jogging, or cycling. The benefit is clear: every single MET of exercise achieved reduces cardiovascular mortality by 12–20%. Even light activity is better than being sedentary.\u003c\/p\u003e\n\u003ch3\u003eWhat is athlete's heart and is it dangerous?\u003c\/h3\u003e\n\u003cp\u003eAthlete's heart is a combination of electrical, structural, and functional changes from intense training, including a 10–20% increase in left ventricle wall thickness and 10–15% larger chambers. It is generally benign and often reversible after detraining, but it can sometimes look like a heart muscle disease that needs expert evaluation.\u003c\/p\u003e\n\u003ch3\u003eCan extreme endurance exercise damage a previously normal heart?\u003c\/h3\u003e\n\u003cp\u003eIn some studies, yes, there is concerning evidence. For example, 12% of 102 veteran marathon runners had heart scarring (fibrosis) on MRI, compared with 4% of sedentary controls. Also, animal studies show exercise-related scarring and arrhythmias. However, this appears rare, and most endurance athletes remain healthy and live longer.\u003c\/p\u003e\n\u003ch3\u003eWhat symptoms during exercise should never be ignored?\u003c\/h3\u003e\n\u003cp\u003eChest pain, fainting, palpitations, or unusual shortness of breath during exercise should never be ignored, especially if you have a family history of heart disease or sudden death. These symptoms could signal an underlying heart condition, so see a doctor promptly for evaluation before continuing your training.\u003c\/p\u003e\n\u003ch3\u003eWhy are black athletes evaluated differently for heart conditions?\u003c\/h3\u003e\n\u003cp\u003eBecause normal heart changes from training differ by ethnicity. Black athletes often have more pronounced ECG repolarization changes, and up to 25% show T-wave inversion that is considered normal. Also, 13% of black male athletes have left ventricle wall thickness over 12 mm, which would be unusual in white athletes.\u003c\/p\u003e\n\u003ch3\u003eAre performance-enhancing drugs dangerous for the heart?\u003c\/h3\u003e\n\u003cp\u003eYes, extremely dangerous. Anabolic steroids and cocaine can cause high blood pressure, arrhythmias, left ventricle hypertrophy, coronary artery disease, heart attacks, heart failure, and sudden cardiac death. These substances carry no safe threshold and should never be used for athletic performance or otherwise.\u003c\/p\u003e\n\u003ch3\u003eWhat is the link between endurance exercise and atrial fibrillation?\u003c\/h3\u003e\n\u003cp\u003eA meta-analysis of 6 studies covering 655 chronic endurance athletes found a 5-fold higher risk of atrial fibrillation compared with sedentary people. The risk increases with over 1,500 lifetime hours of sports or more than 5 hours of intensive exercise per week starting at age 30. This is more likely in middle-aged endurance athletes.\u003c\/p\u003e\n\u003ch3\u003eWhen should an athlete with ECG changes or enlarged heart chambers seek a second opinion to determine whether their heart is a normal athlete's heart or a cardiomyopathy?\u003c\/h3\u003e\n\u003cp\u003eAn athlete should seek a second opinion when cardiac evaluation shows changes that could be either normal training adaptation or a serious heart muscle disease — for example, left ventricular wall thickness above 12 mm, T-wave inversion, or an enlarged right ventricle with abnormal function. These findings are common in athletes, especially black athletes, but when they coexist with symptoms or an abnormal ECG, the overlap with cardiomyopathy is significant. A mistaken diagnosis can cause unnecessary disqualification from sport or leave a dangerous condition undetected. A second opinion from experts in sports cardiology can clarify whether further testing or detraining is needed. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\u003cp\u003eThis patient-friendly article is based on peer-reviewed research published in the \u003cem\u003eEuropean Heart Journal\u003c\/em\u003e.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOriginal title:\u003c\/strong\u003e \"Exercise and the heart: the good, the bad, and the ugly\"\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAuthors:\u003c\/strong\u003e Sanjay Sharma, Ahmed Merghani, and Lluis Mont\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eJournal:\u003c\/strong\u003e European Heart Journal (2015), Volume 36, Issue 23, Pages 1445–1453\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDOI:\u003c\/strong\u003e 10.1093\/eurheartj\/ehv090\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAffiliations:\u003c\/strong\u003e Department of Cardiovascular Sciences, St George's, University of London, UK; and Institut del Torax, Hospital Clinic, Universitat de Barcelona, Spain\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePublished:\u003c\/strong\u003e Received 11 January 2015; accepted 4 March 2015; online publish-ahead-of-print 3 April 2015\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eThis patient-friendly article is based on peer-reviewed research and is intended for educational purposes. It does not replace professional medical advice. Always consult your doctor before making changes to your exercise routine, especially if you have known heart disease or risk factors.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47461166252188,"sku":null,"price":0.0,"currency_code":"KRW","in_stock":true}],"url":"https:\/\/diagnosticdetectives.kr\/products\/exercise-and-the-heart-the-good-the-bad-and-the-ugly-what-patients-need-to-know","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}